The FDA has lost no time in approving Vertex Pharma and CRISPR Therapeutics ... when it was cleared by the FDA for sickle cell disease (SCD). The UK was the first country to give the go-ahead ...

Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...

Investing.com -- Stifel downgraded Vertex (NASDAQ:VRTX), Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation.

In a report released today, Patrick Walravens from JMP Securities maintained a Buy rating on Vertex (VERX – Research Report), with a price ...

Morgan Stanley analyst Chris Quintero maintained a Buy rating on Vertex (VERX – Research Report) today and set a price target of $57.00. The ...

BMO Capital analyst Daniel Jester lowered the firm’s price target on Vertex (VERX) to $41 from $56 and keeps a Market Perform rating on the shares. The firm had previously indicated that shares ...

The watch industry never stops ticking. Keep time with the most exciting new releases from G-Shock, Timex, Citizen and more.

How much of life do we make, and how much of it is fate? Well, according to your birth chart in astrology, there's a ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Curious about when new episodes will drop and how to watch in the UK? Keep reading for all the details. The show officially returned to Paramount Plus on Sunday 23rd February. New episodes are set ...

This article is a text version of a Wall Street Journal newsletter published earlier today. (END) Dow Jones Newswires ...